Sarepta Therapeutics To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday
Media

Sarepta Therapeutics To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday

Latest Ratings for SRPT

Date Firm Action From To
Mar 2022 Morgan Stanley Maintains Equal-Weight
Mar 2022 RBC Capital Maintains Outperform
Feb 2022 Morgan Stanley Maintains Equal-Weight

View More Analyst Ratings for SRPT

View the Latest Analyst Ratings

read more

​ 

​Latest Ratings for SRPT
DateFirmActionFromTo Mar 2022Morgan StanleyMaintainsEqual-Weight Mar 2022RBC CapitalMaintainsOutperform Feb 2022Morgan StanleyMaintainsEqual-Weight
View More Analyst Ratings for SRPT

View the Latest Analyst Ratings

read more 

This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.